[]
Inoue K.: PLP1-related inherited dysmyelinating disorders: Pelizaeus-
Merzbacher disease and spastic paraplegia type 2. Neurogenetics 2005;
6: 1–16.
[]
Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans
Institute of Genetic Medicine, Johns Hopkins University (Baltimore,
MD), {2.07.2013}. World Wide Web URL: http://omim.org/.
[]
Hobson G.M., Kamholz J.: PLP1-Related Disorders. 1999 Jun 15 [Updated
2013 Feb 28]. [w:] Pagon R.A., Adam M.P., Bird T.D., et al., (ed.):
GeneReviews™ [Internet]. Seattle (WA): University of Washington,
Seattle; 1993-2013. Available from: http://www.ncbi.nlm.nih.gov/
books/NBK1182/.
[]
Scheffer I.E., Baraitser M., Wilson J., et al.: Pelizaeus-Merzbacher
disease: classical or connatal? Neuropediatrics 1991; 22: 71–88.
[]
Hudson L.D.: Pelizaeus-Merzbacher disease and spastic paraplegia type
2: two faces of myelin loss from mutations in the same gene. J Child
Neurol. 2003; 18: 616–624.
[]
Hobson G.M., Garbern J.Y.: Pelizaeus-Merzbacher disease, Pelizaeus-
Merzbacher-like disease 1, and related hypomyelinating disorders.
Semin Neurol. 2012; 32: 62–67.
[]
Orthmann-Murphy J., Salsano E., Abrams C., et al.: Hereditary spastic
paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain 2009;
132: 426–438.
[]
Henneke M., Gegner S., Hahn A., et al.: Clinical neurophysiology in
GJA12-related hypomyelinationvsPelizaeus-Merzbacher disease.
Neurology 2010; 74: 1785–1789.
[]
Garbern J.: Pelizaeus-Merzbacher disease. 2011 Oct, Orphanet, http://
www.orpha.net.
[]
Bonkowsky J.L., Nelson C., Kingston J.L., et al.: The burden of inherited
leukodystrophies in children. Neurology 2010; 75: 718–25.
[]
Jędrzejowska M.: Wiotkie dziecko. [w:] Hausmanowa-Petrusewicz I.
(red.)”: Choroby nerwowo-mięśniowe. Wyd. II, Wydawnictwo Czelej
Sp. z o.o., Lublin 2013.
[]
Cailloux F., Gauthier-Barichard F., Mimault C., et al.: Genotype-phenotype
correlation in inherited brain myelination defects due to
proteolipid protein gene mutations. Clinical European Network on Brain
Dysmyelinating Disease. Eur J Hum Genet. 2000; 8: 837–845.
[]
Carvalho C.M., Bartnik M., Pehlivan D., et al.: Evidence for disease
penetrance relating to CNV size: Pelizaeus-Merzbacher disease an
manifesting carriers with a familial 11 Mb duplication at Xq22. Clin
Genet. 2012; 81: 532–541.
[]
Hurst S., Garbern J., Trepanier A., et al.: Quantifying the carrier female
phenotype in Pelizaeus-Merzbacher disease. Genet Med. 2006: 371–
378.
[]
Carrozzo R., Arrigo G., Rossi E., et al.: Multiple congenital anomalies,
brain hypomyelination, and ocular albinism in a female with dup(X) (pter-
->q24::q21.32-->qter) and random X inactivation. Am J Med Genet.
1997; 72: 329–334.
Scholar Google
PubMed